Peak Strength Bio
Research Use Only: For research use only. Not for human consumption. Content is educational and is not medical advice, diagnosis, or treatment.
Peptides / Peptides / Healing & Recovery

BPC-157

High-purity synthetic pentadecapeptide for systemic cytoprotection and tissue repair research.

BPC-157

BPC-157 is a stable, highly researched synthetic peptide consisting of 15 amino acids, modeled after a protective gastric protein. It is widely investigated in preclinical settings for its potential to promote rapid angiogenesis, accelerate ligament and muscle cell regeneration, and protect gastrointestinal mucosal linings.

Typical dose
200 mcg to 500 mcg daily in animal/test models
Half-life
Approximately 4 hours in vivo
Administration
Subcutaneous injection, intramuscular injection, or intranasal administration (experimental)
Research status
Preclinical research use only. Not approved for human consumption.
Calculate a dose

What it is

BPC-157 (Body Protective Compound 157) is a synthetic peptide fragment derived from a gastric protein. It is studied for its role in angiogenesis (new blood-vessel formation), tissue remodeling, and gut protection.

Why researchers use it

  • Supports tendon, ligament, and muscle repair
  • Angiogenesis at injury sites accelerates healing
  • Gut-protective effects; often studied for GI recovery
  • Well-tolerated across preclinical studies

Dosing protocol (for research)

  • Typical range: 250–500 mcg once or twice daily
  • Injury protocols often run 4–6 weeks
  • General recovery: 2–4 weeks

Preparation & injection

  • Reconstitute with bacteriostatic water; swirl gently, do not shake
  • Store refrigerated, protected from light
  • Subcutaneous injection, ideally close to the injury site when appropriate
  • Rotate sites to prevent irritation

Safety notes

  • Generally well-tolerated; mild redness or fatigue possible
  • Sterility and supplier purity are critical
  • Long-term human safety data remains limited

Reconstitution & concentration

Single vial contains 10 mg BPC-157.

  • Reconstitute with 2 mL bacteriostatic water
  • Final concentration: 5 mg/mL
  • Each 0.1 mL (10 units on an insulin syringe) = 0.5 mg (500 mcg)

Common research dosing:

  • Injury-specific: 250–500 mcg daily, injected near the injury site
  • Systemic / GI: 500–1,000 mcg daily SubQ via rotation sites
  • Oral (capsules/sublingual): 500 mcg–1 mg daily for gut-related studies

Duration: 2–6 weeks for acute injuries; 4–8 weeks for GI/systemic support.

Stacks

BPC-157 standalone is a foundation Injury Recovery option — the foundation peptide for recovery studies, frequently combined with TB-500 as the Wolverine Blend for synergistic healing. Researcher tips also note pairing with CJC-1295 + Ipamorelin for recovery-focused protocols.

Where to source